The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus

被引：0
|
作者：
Abby, Stacey L.
Garvey, W. Timothy
Handelsman, Yehuda
Fonseca, Vivian A.
Goldberg, Ronald B.
Rosenstock, Julio
Jones, Michael R.
Markiewicz, Magdalena
Jin, Xiaoping
Misir, Soamnauth
Nagendran, Sukumar
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A173 / A173
页数：1
相关论文
共 50 条
  • [1] Initial Combination Therapy with Metformin Plus Colesevelam in Drug-Naive Hispanic Patients with Early Type 2 Diabetes
    Rosenstock, Julio
    Hernandez-Triana, Eric
    Handelsman, Yehuda
    Misir, Soamnauth
    Jones, Michael R.
    Nagendran, Sukumar
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 7 - 13
  • [2] Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes
    Pi-Sunyer, F. Xavier
    Schweizer, Anja
    Mills, David
    Dejager, Sylvie
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 132 - 138
  • [3] Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus
    Goldberg, Ronald B.
    Rosenson, Robert S.
    Hernandez-Triana, Eric
    Misir, Soamnauth
    Jones, Michael R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (04) : 318 - 324
  • [4] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    DIABETES OBESITY & METABOLISM, 2008, 10 (08): : 675 - 682
  • [5] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [6] Efficacy and safety of saxagliptin in drug-naive Asian patients with type 2 diabetes mellitus: a randomized controlled trial
    Pan, Chang Yu
    Yang, Wenying
    Tou, Conrad
    Gause-Nilsson, Ingrid
    Zhao, June
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 (03) : 268 - 275
  • [7] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Dong Hwa
    Oh, Tae Jung
    Jang, Hak Chul
    Lim, Soo
    DIABETES, 2017, 66 : A346 - A346
  • [8] Epigenetic markers associated with metformin response and intolerance in drug-naive patients with type 2 diabetes
    Garcia-Calzon, Sonia
    Perfilyev, Alexander
    Martinell, Mats
    Ustinova, Monta
    Kalamajski, Sebastian
    Franks, Paul W.
    Bacos, Karl
    Elbere, Ilze
    Pihlajamaki, Jussi
    Volkov, Petr
    Vaag, Allan
    Groop, Leif
    Maziarz, Rlena
    Klovins, Janis
    Ahlqvist, Emma
    Ling, Charlotte
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (561)
  • [9] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    DIABETOLOGIA, 2015, 58 : S54 - S54
  • [10] Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naive Patients with Type 2 Diabetes: Comparison with Metformin
    Goeke, B.
    Hershon, K.
    Kerr, D.
    Calle Pascual, A.
    Schweizer, A.
    Foley, J.
    Shao, Q.
    Dejager, S.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (12) : 892 - 895
12345